The Health Care Equipment and Supplies Industry shows positive seasonality through to September. Will Integra LifeSciences Holdings Corp. be something that you want to hold?
Of the 1655 stocks analyzed on Wednesday, 1553 advanced, 89 declined and the remaining 13 were flat on the day. Gains averaged 2.64% on volumes around 3% less than the day previous. Looking across the capitalizations and returns of 2.80%, 2.58% and 2.87% were seen in Large-caps, Mid-caps and Small-caps, respectively. The percentage of stocks above the 200-day moving average has made a considerable improvement, now sitting at 61.5%, up from 55% witnessed just yesterday. Let’s see if these levels will hold.
Integra LifeSciences Holdings C (IART) Seasonality
Analysis has revealed that with a buy date of April 16 and a sell date of February 19, investors have benefited from a total return of 1733.16% over the last 10 years.This scenario has shown positive results in 7 of those periods.
Conversely, the best return over the maximum number of positive periods reveals a buy date of August 9 and a sell date of August 30, producing a total return over the same 10-year range of 52.33% with positive results in 10 of those periods.
The buy and hold return for the past 10 years was 523.86%.
Comments:
The stock, which has an analyst "outperform" rating, has been in a long-term uptrend since the March 2009 lows.The stock fell under pressure at the beginning of May following the reporting of earnings which were better than expected compared to analysts estimates.The stock has fallen under further pressure over the course of the month as a result of the market turmoil, being deflated almost to oversold territory according to the relative strength index.
Seasonality reveals a strongly positive uptrend from the present timeframe through to mid-July for gains reaching 12.5% on average.Entering into this period of strength, outperformance compared to the market continues to be sought in order to commit new funds without being affected by violent swings in the broad market.Fundamentals are reasonable and value the stock at $44.50, or just over 12% above current levels.
News Headlines for Integra LifeSciences Holdings C (IART)
Equity Clock – By The Numbers will be offered following each trading day.
Disclosure: Mr. Vialoux does not own securities mentioned in this report.
Disclaimer: Comments and opinions offered in this report at EquityClock.com are for information only. They should not be considered as advice to purchase or to sell mentioned securities.
Data offered in this report is believed to be accurate, but is not guaranteed.
Click Here to learn more about the proprietary, seasonal rotation investment strategy developed by research analysts Don Vialoux, Brooke Thackray, and Jon Vialoux.
